---
schema_version: "secwatch.filing_event.v1"
accession: "0001999371-26-004897"
form_type: "8-K"
ticker: "TNXP"
cik: "0001430306"
company_name: "Tonix Pharmaceuticals Holding Corp."
filed_at: "2026-03-03T23:59:59+00:00"
generated_at: "2026-05-15T22:08:16.588538+00:00"
event_type: "other"
sentiment: "positive"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# Tonix Pharmaceuticals uplists from Nasdaq Capital Market to Global Select Market

## Summary
- Nasdaq approved transfer of TNXP common stock, effective March 3, 2026, ticker unchanged.
- Uplisting reflects compliance with higher financial and corporate governance standards.
- CEO Seth Lederman noted uplisting may enhance visibility, liquidity, and institutional access.

## SEC filing metadata
- accession: 0001999371-26-004897
- form_type: 8-K
- ticker: TNXP
- cik: 0001430306
- company_name: Tonix Pharmaceuticals Holding Corp.
- filed_at: 2026-03-03T23:59:59+00:00
- event_type: other
- sentiment: positive
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 7.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1430306/000199937126004897/0001999371-26-004897-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1430306/000199937126004897/tnxp-8k_030326.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001999371-26-004897
- JSON: https://secwatch.observer/filing/0001999371-26-004897.json
- Plain text: https://secwatch.observer/filing/0001999371-26-004897.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.